Business Development

  • 2010

    8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...

    Read More >

  • Meet us

    The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...

    Read More >

Business Development

Out-licensing

Zealand aims to establish partnerships with major pharmaceutical companies after having established “proof-of-concept”,  or earlier if such partnership will advance the development of Zealand Pharma’s development candidates.  

Contact person:

Arvind M. Hundal
Director of Business Development
Phone:    +45 43 28 12 46
e-mail:   amh@zp.dk

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.